-
Sorafenib Shown to Reverse PAH in Rat Model
Read about a new study of rats that suggests treatment with the anti-cancer medication sorafenib may be successful in PAH patients.
Click here to find out more about this study and its results.
What are your thoughts on this news?
-
1 Reply
-
This is so cool! The results suggested that sorafenib “significantly and dose-dependently reversed cardiopulmonary remodeling and PAH at even a low dose (10 mg/kg).” The researchers believe “a low-dose sorafenib therapy may be a suitable therapeutic agent for PAH.” This is exciting, especially because this medication is already used in humans to treat cancer. I hope the trial advances quickly.
Developments like this give me hope that a cure for PH is on its way. What kind of research developments do you look for?
There are lots of trials done on medications already being used to treat PH, but I’m most excited about new medications or new pathways to target. What gets you excited?
Log in to reply.